{
  "@context": "https://frontierpicks.com/schemas/dossier.v1.json",
  "ticker": "RCMT",
  "name": "RCM Technologies, Inc.",
  "url": "https://frontierpicks.com/dossiers/RCMT/",
  "json_url": "https://frontierpicks.com/dossiers/RCMT.json",
  "status": "DORMANT",
  "current_conviction": "MEDIUM",
  "graded_conviction": null,
  "archetype": {
    "code": "a2",
    "n": 2
  },
  "current_thesis": "Engineering-led re-rating: Q2 (2026-08-14) put Engineering revenue at $39.5M, +49% YoY, on a $14.7M jump in energy services, and both covering brokers moved to $45 on 2026-08-17. The narrative is accelerating but the tape is stretched — RSI(14) 84.6 into a 2026-08-28 close of $41.84, 0.4% under the 52-week high, with no company-dated catalyst until the Q3 print in early November.",
  "invalidation_trigger": "A weekly close below $32.50 erases the entire 2026-08-14 earnings move (insider 10b5-1 sales printed $32.50–$35.00 that day); secondarily, a Q3 print showing Engineering energy-services revenue flat or lower sequentially against the record 2026 backlog.",
  "catalyst_date": null,
  "outcome": "OPEN",
  "outcome_date": null,
  "invalidation_fired": null,
  "themes": [
    "managed-care-health-services",
    "industrial-power-grid",
    "cyclical-industrials"
  ],
  "tags": [],
  "sources": [],
  "notes": [
    "Float is small: 7,087,614 shares outstanding as of the Q2 2026 report, so intraday liquidity is thin and spreads widen quickly in drawdowns.",
    "Fiscal calendar is a 52/53-week year — Q2 FY2026 ended 2026-07-04, so quarter-end dates shift a few days year to year.",
    "Coverage is two firms deep (B. Riley, Benchmark), both at $45 as of 2026-08-17; a single rating change is a large share of published sponsorship.",
    "Executives sell under Rule 10b5-1 plans alongside RSU/PSU vesting, so scheduled dispositions do not by themselves signal a view.",
    "Company runs an active repurchase program under a 2024-03-29 authorization; share count declines are a recurring per-share driver."
  ],
  "body_markdown": "## Current Thesis\nThe narrative on offer is a staffing-and-engineering microcap that has stopped being a staffing microcap. Q2 2026, reported 2026-08-14 for the thirteen weeks ended 2026-07-04, put consolidated revenue at $93.8M against $78.2M a year earlier, +20.0%, and Engineering at $39.5M, +49% YoY, with the growth traced primarily to a $14.7M increase in energy services. Adjusted diluted EPS of $0.82 cleared the $0.62 consensus; revenue cleared $81.7M consensus. Three days later B. Riley Securities and Benchmark both maintained Buy and raised targets to $45. That is the leg: engineering labor supplied into a power and energy capex cycle, sold through a share count that has been shrinking for years — 7,087,614 shares outstanding at the Q2 report, with roughly 264k retired year-to-date via repurchase.\n\nThe narrative is accelerating — the 2026-08-14 beat is the first quarter in which the energy-services line was large enough to carry the whole company, the two 2026-08-17 target raises are fresh institutional marks, and the 2026-08-28 close of $41.84 sits 0.4% below the 52-week high of $42.00 after a three-month price change of +86%. What it does not yet have is a second confirming print or a wider sponsor list.\n\n## Bull Case\n- Engineering revenue $39.5M in Q2 2026 vs the prior-year quarter, +49%, driven primarily by a $14.7M increase in energy services (2026-08-14 release). This is the segment the market is paying for.\n- Engineering delivered its best gross profit quarter on record at $6.9M, with 2026 Engineering backlog reported above $70M versus roughly $21M at the same point in 2025 (Q2 2026 earnings commentary, 2026-08-14, as summarized by Staffing Industry Analysts). Backlog of that shape argues the second half is contracted rather than hoped for.\n- GAAP net income $4.9M / $0.68 diluted, against $3.8M / $0.50 in the comparable 2025 quarter — earnings growing faster than the share count is shrinking.\n- Capital structure is doing work: cash $6.6M at 2026-07-04 versus $2.9M at 2026-01-03, revolver outstanding $23.4M, and a float of 7.09M shares. On a base that small, retiring ~264k shares year-to-date is a material per-share lever.\n- Both covering brokers moved to $45 on 2026-08-17 and kept Buy ratings. That is thin coverage, which cuts both ways, but it means the re-rating has not yet been absorbed by a crowded sell-side.\n\n## Bear Case\n- Consolidated gross margin fell to 25.7% from 28.5% a year earlier. Revenue grew 20.0% while gross profit grew only 8.1% ($24.1M vs $22.3M) — the mix shift into energy services is dilutive to margin, and a growth story running on lower-margin dollars re-rates differently than one running on price.\n- Insiders sold into the print. CFO Kevin D. Miller reported open-market dispositions across 2026-08-14 to 2026-08-18 at prices from $34.02 to $42.00.\n- Specialty Health Care, at $44.7M in Q2 2026, is still the largest segment by revenue and is levered to school-district staffing budgets, a cycle with nothing to do with energy capex and its own funding risk.\n- Energy-services strength is concentrated by construction. A $14.7M year-over-year increase in a single line inside a $93.8M quarter means one program delay changes the growth rate materially.\n- $23.4M drawn on the revolver against $6.6M of cash leaves limited room to fund both working capital for a growing Engineering book and continued repurchase.\n\n## Setup & Price Structure\nThe 2026-08-28 close of $41.84 is 0.4% under the 52-week high of $42.00, with RSI(14) at 84.6 and a three-month price change of +86%. That combination — a new high, an RSI in the mid-80s, and a doubling inside a quarter on a 7.09M-share count — is the signature of a re-rating that has already pulled forward a good deal of the news, not of a base.\n\nThe 2026-08-14 print is the structural reference. Insider 10b5-1 sales that day printed between $32.50 and $35.00, which brackets the pre-gap zone; the CFO's subsequent sales ran up to $42.00. A pullback that holds above the $34–$35 shelf keeps the post-print structure intact; a weekly close under $32.50 means the entire earnings reaction has been given back and the re-rating is being repriced rather than digested.\n\nCrowding evidence, stated as observables rather than a verdict: two brokers at $45 versus a $41.84 close leaves a narrow published gap; RSI 84.6; insider dispositions in four of the five sessions following the print; no confirmed company event inside the next 30 days. There is no visible retail-forum clustering on this name and no meme-desk coverage, which distinguishes it from a squeeze setup.\n\n## Catalyst Calendar (next 30 days)\n\n- No confirmed company-dated catalyst falls inside 2026-08-29 to 2026-09-28. The Q2 reporting cycle closed on 2026-08-14 and the target revisions landed 2026-08-17.\n- ~2026-10-03 (est.) — fiscal Q3 2026 period end (52/53-week fiscal calendar; Q2 ended 2026-07-04).\n- ~2026-11-05 (est.) — Q3 FY2026 print and call. This is the next dated test of whether the >$70M 2026 Engineering backlog converts and whether energy services grows sequentially off the Q2 base.\n\n## Elapsed catalysts\n\n- Ongoing, undated: Form 4 filings. Insider activity has been the only fresh RCMT disclosure since 2026-08-18. *(passed 11d ago)*\n\n## What Would Change Our Mind\nThe structure that matters is the 2026-08-14 gap. Losing it wholesale says the energy-services re-rating was a one-quarter event that the market has decided not to capitalize: a weekly close below $32.50 puts price back under the level where insiders transacted on print day and removes the reference the whole advance was built on. A slower break of the thesis would be the Q3 print in early November showing Engineering energy-services revenue flat or down sequentially, or gross margin compressing again below 25.7% while revenue grows — that is the specific combination that turns \"operating leverage\" into \"buying revenue.\"\n\nTwo further conditions would matter. First, the narrative turning saturated: mainstream or generalist coverage arriving on a 7.09M-share float without new institutional buyers behind it, visible as declining volume on advances. Second, either broker cutting the $45 target or moving off Buy — with only two covering firms, one downgrade removes half the published support.\n\nThe upside case confirms in the other direction: an Engineering backlog figure above $70M restated higher at the Q3 print, with gross margin stabilizing, would argue the 2026-08 move was a re-rating to a new earnings level rather than a momentum overshoot.\n\n## Correlation Notes\nRCMT trades against three loosely related books. The Engineering segment ties it to the power and utility engineering complex — the same demand pool that drives NV5 Global, Willdan and the broader T&D services group; a capex deferral headline from a large utility or grid operator would pressure all of them together. Specialty Health Care at $44.7M ties it to school-based and per-diem healthcare staffing, which moves with district budget cycles and has no relationship to the energy narrative; that segment is why the name does not cleanly track a pure infrastructure basket. Third, at 7,087,614 shares outstanding the stock behaves like a microcap: it will correlate with small-cap risk appetite (IWM/Russell 2000 breadth) far more than its fundamentals justify on any given week, and liquidity thins fast in a drawdown. The buyback creates a persistent, price-insensitive bid that dampens ordinary selloffs but is capped by the $23.4M revolver balance against $6.6M of cash.",
  "first_seen": "2026-08-26",
  "last_analyzed": "2026-08-29T07:29:20+00:00",
  "last_synthesized": "2026-08-29",
  "last_update_source": "watchlist_research",
  "license": "Content © FrontierPicks. Cite the canonical URL."
}